Erytech Pharma | |
Stock Exchange | Euronext Paris |
EPS |
EUR2.13 |
Market Cap |
EUR113.53 M |
Shares Outstanding |
17.94 M |
Public Float |
15.9 M |
Address |
Bâtiment Adénine Lyon Rhone-Alpes 69008 France |
Employees | - |
Website | http://www.erytech.com |
Updated | 07/08/2019 |
ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. It engages in developing and producing therapeutic products for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. |